The Newsroom
Item 1 of 3
AdventHealth Research Institute Offers Phase II Clinical Trial of Etanercept for Treatment of Blast-Induced Tinnitus
Approximately 1 billion people throughout the world suffer from tinnitus (ringing in the ears), and it is the number one disability of those who serve in the U.S. military. The condition can disrupt...
Item 2 of 3
AdventHealth’s Karen D. Corbin, PhD, RD, Contributed to New American Diabetes Association Consensus Statement on Liver Disease in Diabetes
Item 3 of 3
AdventHealth East Orlando First in Florida to Earn Advanced Foot & Ankle Surgery Certification from DNV
Recent Stories at AdventHealthMD
-
-
Clinical ExcellenceAdventHealth Inflammatory Bowel Disease Clinic Adds Intestinal Ultrasound to Help Evaluate and Guide Treatment
-
InnovationAdventHealth Daytona Beach Surgeon First in Florida to Perform Robotic-assisted Convergent Hybrid Ablation Procedure
-
InnovationPediatric Orthopedic Surgery Team Reaches Milestone with Bridge-Enhanced Anterior Cruciate Ligament Repair (BEAR®) Implant and Advances Surgical Approach
-
Clinical ExcellenceRespiratory Virus Testing Guidance for Flu Season
-
Clinical ExcellenceAdventHealth Celebration Introduces New Intraoperative Molecular Imaging Process to Improve Accuracy of Lung Cancer Surgery
-
Clinical ExcellenceAn incredible journey through two open heart surgeries at AdventHealth
-
Clinical ExcellenceUsing Genomics and AI to Improve Breast Cancer Risk Assessment and Early Detection
-
Clinical ExcellenceNew Research Published in New England Journal of Medicine Finds That Adjuvant Pembrolizumab Extends Disease-Free Survival in Muscle-Invasive Urothelial Carcinoma